As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of decreasing hormone levels have come to the forefront as a quality-of-life issue for patients and their families. For the past two decades, the healthcare industry has responded to this clinical need by developing, testing and marketing hormone replacement therapy (HRT) products. Because of their ease-of-use and dosing characteristics, drug developers are continuing to turn to transdermal delivery systems for HRT products. There are more than 40 million post-menopausal women in the United States alone, and this group is expected to grow by 50% by 2020. With the aging of the population worldwide, conditions and diseases such as menopause, osteoporosis and heart disease, which may benefit from hormone replacement therapy, are expected to become significantly more prevalent. The industry continues to attract interest in the form of new participants and products. While the global market continues to be dominated by the FDA-approved HRT products of major pharmaceutical firms, regional markets are a bit more competitive, and present unique challenges to transdermal HRT sector participants.


· Analyzes and evaluates the global market opportunity for transdermal hormone replacement and assesses the probable impact of evolving regulatory, economic and demand factors
· Assesses transdermal products approved or in development for the delivery of therapeutic hormones
· Provides detailed descriptions of hormone replacement treatment segments, market factors, and business strategies
· Forecasts transdermal hormone replacement product demand to 2016 by geographic region and product segment
· Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

Table Of Contents

Summary of Contents

Executive Summary

Scope and Definitions
The Hormone Replacement Therapy Market
The Opportunity for Transdermal Hormone Replacement Therapy

The Hormone Replacement Therapy Market Opportunity

Evolution in HRT Guidelines
Regional Factors in HRT Practice
Hormone Replacement Therapy Demand Drivers 
Competitive Landscape
Factors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal HRT Patches
Patch Designs and Construction
Transdermal Patch Manufacturing and Packaging
The Patch Manufacturing Ecosystem
Patch Economics
Transdermal HRT Gels
Transdermal Formulations
IP and Proprietary Technology
Limitations of Topical Gels and Emulsions
Transdermal HRT Sprays

Transdermal HRT Indications and Markets

Vasomotor Symptoms
Vaginal Atrophy
Postmenopausal Osteoporosis

Transdermal HRT Product Assessments and Market Prospects

Approved Transdermal HRT Products
  Bayer Healthcare 
  KV Pharm 
  Watson Laboratories 
  Faran SA 
Estradiol Levonorgestrel
  Bayer Healthcare
  Abbott Labs 
  Endo Pharms 
  Watson Laboratories 
Development-Stage Transdermal HRT Products
Other Hormones

Transdermal Hormone Replacement Market Factors 

Regional Regulations 
Clinical Trials 
Quality and Reliability
Indications Prescribing Guidelines and Off-Label Prescribing
Managed Care and Payor Initiatives
Rx-to-OTC Switching

Market Forecasts

Forecast Methodology
Forecasts by Region
Forecasts by Drug Class
Forecasts by Delivery Form Factor
Market Share Data 

Market Participant Profiles

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Detailed I/E report of Carbendazim export analysis

Detailed I/E report of Carbendazim export analysis

  • $ 5 400
  • Industry report
  • July 2014
  • by CCM International Limited

Carbendazim export analysis will help clients indentify export situation of technical and formulations with exclusive research methods, to offer not only the target products' export volume, price, time, ...

Global Pediatric Drugs and Vaccines Market

Global Pediatric Drugs and Vaccines Market

  • $ 4 950
  • Industry report
  • September 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective ...

Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid (TGA) and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid (TGA) and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • $ 4 795
  • Industry report
  • August 2014
  • by Transparency Market Research

Monochloroacetic acid (MCA) is a halogenated derivative of acetic acid. It is used in the production of a variety of compounds and intermediates. MCA is majorly used in the production of carboxymethyl ...

2 Companies

Company Profiles

Roche Holding AG


Genentech Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.